Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 3, Issue 6, pp. 335-343
PubMed
Published By
Print ISSN
Online ISSN
History
- April 1, 2005
- August 1, 2004
- February 28, 2005
- Published first June 22, 2005.
Copyright & Usage
American Association for Cancer Research
Author Information
- Peter Horak1,
- Dietmar Pils1,
- Griet Haller1,
- Ingrid Pribill1,
- Max Roessler1,
- Sandra Tomek1,
- Reinhard Horvat3,
- Robert Zeillinger2,
- Christoph Zielinski1 and
- Michael Krainer1
- 1Clinical Division of Oncology, Department of Medicine I; 2Department of Gynecology and Obstetrics; and 3Department of Clinical Pathology, University Hospital Vienna, Vienna, Austria
- Michael Krainer, Clinical Division of Oncology, Department of Medicine I, University Hospital, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Phone: 43-1-40400-4449; Fax: 43-1-40400-4451. E-mail: michael.krainer{at}meduniwien.ac.at
June 2005
Volume 3, Issue 6
Volume 3, Issue 6
Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer
Jump to section
Advertisement